List of Medrio eConsent Customers
San Francisco, 94104, CA,
United States
Since 2010, our global team of researchers has been studying Medrio eConsent customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Medrio eConsent for Governance, Risk and Compliance from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Medrio eConsent for Governance, Risk and Compliance include: Freenome, a United States based Life Sciences organisation with 425 employees and revenues of $500.0 million, Digital Medicine Society, a United States based Non Profit organisation with 40 employees and revenues of $6.0 million, Swing Therapeutics, a United States based Life Sciences organisation with 33 employees and revenues of $5.0 million and many others.
Contact us if you need a completed and verified list of companies using Medrio eConsent, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Medrio eConsent customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Digital Medicine Society | Non Profit | 40 | $6M | United States | Medrio | Medrio eConsent | Governance, Risk and Compliance | 2023 | n/a |
In 2023, Digital Medicine Society deployed Medrio eConsent to support a fully remote clinical research study focused on nocturnal scratching in atopic dermatitis. The deployment used Medrio eConsent in the Governance, Risk and Compliance category to centralize informed consent capture and auditability for research and clinical trials in the United States.
Medrio eConsent was configured to enable participants to review and sign consent from home, providing an auditable consent trail and electronic evidence of participant agreement. Implementation emphasized remote consent workflows, electronic signature capture, timestamped audit logs and centralized consent records to support regulatory documentation and study oversight.
The implementation was completed in less than two weeks, reducing site burden and accelerating participant recruitment and onboarding for the study. Operational coverage was research and clinical trials with participant facing workflows managed remotely, improving study oversight and compliance through clear recordability and traceable consent events.
Governance adjustments centered on using the auditable consent trail as the authoritative consent record and streamlining review processes for study monitors and compliance teams. The rapid, cloud oriented deployment pattern and centralized consent repository supported faster onboarding and simplified documentation for ongoing trial governance.
|
 |
Freenome | Life Sciences | 425 | $500M | United States | Medrio | Medrio eConsent | Governance, Risk and Compliance | 2023 | n/a |
Freenome implemented Medrio eConsent in 2023 to support Governance, Risk and Compliance for large scale oncology screening trials. The deployment was part of a broader Medrio footprint that included CDMS EDC and ePRO, and it was configured to operate across research and clinical trials spanning 200 plus sites and tens of thousands of participants in United States and global cohorts.
Medrio eConsent was configured to enable remote and hybrid consenting workflows, supporting electronic consent capture, consent versioning and audit trails consistent with clinical research compliance practices. The implementation emphasized participant facing workflows to improve convenience and retention, and standard consent templates were instrumented alongside site level configuration to accommodate remote enrollment and in clinic consenting.
Integration work leveraged Medrio API capabilities to link eConsent with the Medrio CDMS EDC and ePRO systems, accelerating site onboarding and streamlining consent data flow into study monitoring and data cleaning processes. The API integrations supported centralized monitoring and query management, improving data quality and enabling faster review cycles across the high volume, multi site study program.
Governance focused on standardized consenting procedures, version control and site training to maintain regulatory compliance and support hybrid operations. Reported outcomes included improved participant convenience and retention and improved data quality and monitoring across the program, reflecting operational alignment between Medrio eConsent, Medrio CDMS EDC and ePRO for Freenome clinical research activities.
|
|
|
Swing Therapeutics | Life Sciences | 33 | $5M | United States | Medrio | Medrio eConsent | Governance, Risk and Compliance | 2021 | n/a |
In 2021 Swing Therapeutics deployed Medrio eConsent as part of a broader Medrio suite to enable a decentralized clinical trial model for its digital therapeutic Stanza, supporting remote consenting and patient reported outcome capture for research and clinical trials in the United States. The implementation is framed within the Governance, Risk and Compliance category and focused on electronic consent workflows and compliant PRO capture across remote study participants.
The technical implementation included Medrio CDMS/EDC, eCOA/ePRO and Medrio eConsent modules, configured to support remote enrollment workflows, automated consent versioning and electronic audit trails. Automation features were used to orchestrate consent completion triggers and ePRO scheduling, standardizing data capture and reducing manual site tasks while maintaining source data integrity and compliance controls.
Operational coverage centered on clinical operations and site coordination, extending consent and PRO collection beyond physical sites to remote participants, which supported high participant compliance. The deployment emphasized electronic documentation and audit logs that feed regulatory-ready datasets, aligning consent provenance with clinical data collection for downstream submission workflows.
Governance and process changes included standardizing remote consent templates and enforcing automated workflow checkpoints to ensure regulatory compliance and traceability. Those structural changes, combined with Medrio eConsent and the suite configuration, expanded remote enrollment, freed up site resources, and contributed to the data quality and compliance that supported Swing Therapeutics regulatory submission and subsequent FDA De Novo authorization.
|
Buyer Intent: Companies Evaluating Medrio eConsent
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||